Searched for
WHAT IS STOCK BUYOUT
Musk’s SpaceX adds billions in debt while cutting interestElon Musk's SpaceX has successfully issued $25 billion in investment-grade bonds, a move that consolidates debt from X and xAI while loweri...- Inside Cursor's journey to a $60 billion deal with Elon Musk’s SpaceXSpaceX has acquired AI coding assistant Cursor for $60 billion in an all-stock deal, significantly bolstering its AI ambitions. This move p...
- Global Markets: European shares edge higher with banks in the lead; the Middle East in focusEuropean markets saw a rise on Tuesday. Banking stocks led the gains, with Italian lenders drawing attention. Tech stocks stabilized after ...
- Ex-Peak XV trio raises Mettle; Fintechs go licence huntingHappy Thursday! Three former Peak XV MDs, who abruptly left the VC firm, are launching Mettle Capital to back Indian startups. This and mor...
- Groww investors make bank; Mobikwik, Fractal's Q4 profits surgeGroww delivered strong returns to early investors after the IPO lock-in expired. This and more in today's ETtech Top 5.
- Microsoft stock price, earnings, investor relations and quarterly cloud revenue growth fall after cloud results and AI spending updatesMicrosoft stock price, earnings, investor relations and quarterly cloud revenue growth remained in focus after the company reported Azure g...
- 80 seconds of big tech earnings will decide stock market’s fateInvestors await earnings reports from Alphabet, Meta, and Microsoft after trading ends Wednesday. These tech giants' results will guide mar...
- Sun Pharma deal structurally strong, debt the only overhang: Amit KhuranaMarket expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma's acquisition is seen as strategically ...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- After layoffs, Microsoft targets 7% of US workforce for buyouts - who’s affected?Microsoft is offering voluntary retirement buyouts to approximately 7% of its U.S. workforce for the first time in its 51-year history. Thi...
- Uber shocks Wall Street with massive $20 billion buyback: What it means and why companies do itUber's second-quarter results exceeded expectations, with an 18% revenue increase and a matching earnings per share forecast. The company a...
- Elon Musk's mysterious ways on display in Tesla tweet trialThe trial, centered on a pair of tweets announcing Musk had obtained the money to take Tesla private in 2018, reeled the 51-year-old billio...
- Elon Musk defiantly defends himself in Tesla tweet trialElon Musk returned to federal court to defend himself against a class-action lawsuit that alleges he misled Tesla shareholders with a tweet...
- Brokerage views: Tata Steel, Sun Pharma, JP AssociatesDealers are expecting trade to remain choppy ahead of IIP and inflation data. Here's what they recommend to counter that.
- Cairn India, Sesa Goa stocks fall as Vedanta deal further delayedShares of Cairn India fell by nearly 2 per cent in morning trade on the BSE today after the government referred the deal to a ministerial p...
- PE majors in $1bn joint bid for PatniThe move could be significant and the first instance of PE majors coming together to aggressively pursue a large acquisition in India.
- Liquidity flowing into emerging markets will help Hindalco move up: Seshadri BharathanSeshadri Bharathan, MD & CEO, KSEMA Fincon Ltd. in an interview with ET Now talks about Hindalco.
- Blackstone records first loss since IPOThe loss was Blackstone’s second since its June 2007 initial public offering, which capped a two-year boom in leveraged buyouts.
- Bosses sell their cos, get millions & keep jobs tooFor sinful corporate behaviour, it is hard to beat the multiple millions bosses heap on themselves when they sell their companies.
Load More
